COCRYSTAL PHARMA INC (COCP) Stock Balance Sheet
USA - NASDAQ:COCP - US19188J4094 - Common Stock
1.25 USD
0 (0%)
1.22 USD
-0.03 (-2.4%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 9.86M | N/A | N/A | N/A | |||
| Cash Equivalents | N/A | N/A | 26.35M | 37.10M | 58.70M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 1.64M | 1.22M | 890.00K | 700.00K | 0.00 | |||
| Other Current Assets | 357.00K | 505.00K | 1.85M | 2.30M | 700.00K | |||
| Total Current Assets | 6.76M | 11.58M | 29.09M | 40.20M | 59.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.65M | 1.85M | 2.12M | 600.00K | 900.00K | |||
| Investments And Advances | 88.00K | 29.00K | 46.00K | 0.00 | 0.00 | |||
| Goodwill | N/A | N/A | N/A | 0.00 | 19.10M | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 1.74M | 1.88M | 2.17M | 600.00K | 20.10M | |||
| TOTAL ASSETS | 8.51M | 13.46M | 31.26M | 40.80M | 79.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 975.00K | 886.00K | 2.04M | 600.00K | 900.00K | |||
| Accounts Payable | 856.00K | 1.54M | 1.22M | 600.00K | 600.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Total Current Liabilities | 1.83M | 2.43M | 3.26M | 1.20M | 1.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 1.34M | 1.50M | 1.61M | 100.00K | 300.00K | |||
| Total Non-Current Liabilities | 1.34M | 1.50M | 1.61M | 100.00K | 300.00K | |||
| TOTAL LIABILITIES | 3.17M | 3.93M | 4.88M | 1.30M | 1.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -337.77M | -333.42M | -315.91M | -297.90M | -259.10M | |||
| Additional Paid In Capital | 343.10M | 342.93M | 342.29M | 337.50M | 336.50M | |||
| Common Shares | 10.00K | 10.00K | 10.00K | 0.00 | 100.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 10.17M | 10.17M | 10.17M | 8.10M | 8.10M | |||
| Tangible Book Value per Share | 0.52 | 0.94 | 2.59 | 4.89 | 7.21 | |||
| Total Shareholders' Equity | 5.33M | 9.52M | 26.38M | 39.60M | 77.50M | |||
| TOTAL LIABILITIES AND EQUITY | 8.51M | 13.46M | 31.26M | 40.80M | 79.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 3.69 | 4.77 | 8.92 | 33.50 | 39.53 | |||
| Return On Assets (ROA) | -147.70% | -133.77% | -57.58% | -95.20% | -17.87% | |||
| Return On Equity (ROE) | -235.55% | -189.02% | -68.22% | -98.08% | -18.31% | |||
All data in USD , ROIC based on taxRate of 0.21